Skip to main content
Equibles

Kera Capital Partners, Inc.

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 2040353 SACRAMENTO, CA
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$291,062
-$6,974 QoQ
Shares Held
26,826
0.0% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#96
of 161 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Derivatives in PHAT

reported options exposure · as of Jun 30, 2026
CallValue
$54,250
CallShares
5,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Kera Capital Partners, Inc. holds $3,255,768 across 11 Biotechnology names. PHAT ranks #5 (8.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 6,351 $719,949
2 JAZZ
Jazz Pharmaceuticals plc
 2,297 $553,508
3 KYTX
Kyverna Therapeutics, Inc.
 40,000 $356,400
4 FDMT
4D Molecular Therapeutics, Inc.
 24,068 $320,104
5 PHAT
Phathom Pharmaceuticals, Inc.
This page 		26,826 $291,062
6 REGN
Regeneron Pharmaceuticals, Inc.
 377 $235,074
7 TECH
BIO-TECHNE Corp
 3,287 $232,226
8 VRTX
Vertex Pharmaceuticals Inc / Ma
 448 $222,535

All Filings in PHAT

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $54,250 5,000
2026-06-30 $291,062 26,826
2026-03-31 $298,036 26,826
2025-12-31 $402,390 24,255
2025-09-30 $353,794 30,059
2025-06-30 $288,265 30,059
2025-03-31 $187,153 29,849
2024-12-31 $218,013 26,849